Substituted anilines as CCR(4) antagonists

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9758512
APP PUB NO 20160317545A1
SERIAL NO

15207315

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Aniline compounds are provided which bind to CCR(4) and are useful for the treatment of diseases such as allergic diseases, autoimmune diseases, graft rejection and cancer.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CHEMOCENTRYX INC850 MAUDE AVENUE MOUNTAIN VIEW CA 94043

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Charvat, Trevor T San Jose, US 24 557
Fan, Junfa Foster City, US 37 286
Lange, Christopher W El Cerrito, US 32 113
Leleti, Manmohan Reddy Cupertino, US 79 594
Li, Yandong San Jose, US 52 509
Mali, Venkat Reddy Cupertino, US 56 249
McMahon, Jeffrey P San Francisco, US 21 103
Powers, Jay Pacifica, US 39 433
Punna, Sreenivas Sunnyvale, US 76 941
Yang, Ju Palo Alto, US 72 605

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Mar 12, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 12, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00